Literature DB >> 10399664

Mitral valve compensation for annular dilatation: in vitro study into the mechanisms of functional mitral regurgitation with an adjustable annulus model.

S He1, J D Lemmon, M W Weston, M O Jensen, R A Levine, A P Yoganathan.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Mitral annulus dilatation has been identified as an important factor in functional mitral regurgitation (FMR). However, the pathophysiologic interaction of annular dilatation and papillary muscle (PM) displacement in FMR, which occurs clinically in left ventricular (LV) dilatation, is still not well understood. It is difficult to separate these competing factors in vivo, leading to confusion in identifying the real role of the annular dilatation in FMR and its interaction with PM displacement.
METHODS: To better understand the competing factors, an in vitro model was developed with a D-shaped adjustable mitral annulus that could be changed from 5.5 cm2 to 13.0 cm2 during experiments, independent of varying PM positions. Six excised normal porcine mitral valves were mounted in a left ventricular model with the adjustable annulus device and tested in a physiologic pulsatile flow system under normal cardiac output and left ventricular pressure (5.0 l/min, 120 mmHg). Papillary muscles were placed in normal and then displaced to an apical posterolateral position, to simulate pathological conditions seen clinically. Regurgitation was measured directly by a flow probe and the mitral valve geometry and leaflet coaptation were recorded by video camera through the model's atrium window. In addition, 2D echocardiography was used to evaluate leaflet coaptation and color Doppler flow mapping to detect the regurgitant flow field.
RESULTS: The results showed that in normal PM position, the mitral regurgitant was consistently at low level until the annulus was enlarged to 1.75 times the normal size, at which time it increased sharply. Papillary muscle apical posterolateral displacement, which simulates a dilated LV, caused regurgitation to occur earlier (1.5 times the normal annulus size), and had an increased regurgitant volume (p < 0.05). The leaflet gaps were first observed at the commissural areas of the valves, consistent with the location of regurgitant jets detected by color Doppler flow mapping. Asymmetric PM displacement created more regurgitation than both the symmetric PM tethering (p = 0.063) and normal PM position (p < 0.01). The regurgitant jets were observed at the same commissural side as the PM displacement, even without significant enlargement of the annulus.
CONCLUSIONS: This in vitro study provides insight into the interaction between annular dilatation and PM displacement on FMR. The resulting effects and their overall similarity to clinical observation could help further understand the mechanism of FMR and provide additional information to improve future therapeutic strategies.

Entities:  

Mesh:

Year:  1999        PMID: 10399664

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  11 in total

1.  Contribution of myocardium overlying the anterolateral papillary muscle to left ventricular deformation.

Authors:  Akinobu Itoh; Elizabeth H Stephens; Daniel B Ennis; Carl-Johan Carlhall; Wolfgang Bothe; Tom C Nguyen; Julia C Swanson; D Craig Miller; Neil B Ingels
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

2.  Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study.

Authors:  Christos G Mihos; Orlando Santana
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Cardioband for the treatment of secondary mitral regurgitation: a viable percutaneous option?

Authors:  Evin Yucel; Orlando Santana; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

4.  Left ventricle-mitral valve ring size mismatch: understanding the limitations of mitral valve repair for ischemic mitral regurgitation.

Authors:  Christos G Mihos; Evin Yucel; Orlando Santana
Journal:  Ann Transl Med       Date:  2017-01

5.  Effects of annular contraction on anterior leaflet strain using an in vitro simulator with a dynamically contracting mitral annulus.

Authors:  Thomas F Easley; Charles H Bloodworth; Vinay Bhal; Ajit P Yoganathan
Journal:  J Biomech       Date:  2017-11-21       Impact factor: 2.712

6.  Fluid-Structure Interaction Analysis of Papillary Muscle Forces Using a Comprehensive Mitral Valve Model with 3D Chordal Structure.

Authors:  Milan Toma; Morten Ø Jensen; Daniel R Einstein; Ajit P Yoganathan; Richard P Cochran; Karyn S Kunzelman
Journal:  Ann Biomed Eng       Date:  2015-07-17       Impact factor: 3.934

7.  Mitral valve mechanics following posterior leaflet patch augmentation.

Authors:  Azadeh Rahmani; Ann Q Rasmussen; Jesper L Honge; Bjorn Ostli; Robert A Levine; Albert Hagège; Hans Nygaard; Sten L Nielsen; Morten O Jensen
Journal:  J Heart Valve Dis       Date:  2013-01

8.  Acute geometric changes of the mitral annulus after coronary occlusion: a real-time 3D echocardiographic study.

Authors:  Jun Kwan; Beom Woo Yeom; Michael Jones; Jian Xin Qin; Arthur D Zetts; James D Thomas; Takahiro Shiota
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

9.  In vitro mitral valve simulator mimics systolic valvular function of chronic ischemic mitral regurgitation ovine model.

Authors:  Andrew W Siefert; Jean Pierre M Rabbah; Kevin J Koomalsingh; Steven A Touchton; Neelakantan Saikrishnan; Jeremy R McGarvey; Robert C Gorman; Joseph H Gorman; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2013-01-29       Impact factor: 4.330

10.  Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy.

Authors:  Elizabeth H Stephens; Tomasz A Timek; George T Daughters; Joyce J Kuo; Aaron M Patton; L Scott Baggett; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.